New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 17, 2023 - The FDA announced the approval of Sanofi and AstraZeneca’s Beyfortus (nirsevimab-alip).
Download PDF
Return to publications
